BlackRock’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.15B | Buy |
|
|||||
|
2024
Q4 | $511M | Sell |
|
|||||
|
2024
Q3 | $455M | Sell |
|
|||||
|
2024
Q2 | $433M | Sell |
|
|||||
|
2024
Q1 | $559M | Sell |
|
|||||
|
2023
Q4 | $587M | Buy |
|
|||||
|
2023
Q3 | $391M | Sell |
|
|||||
|
2023
Q2 | $481M | Buy |
|
|||||
|
2023
Q1 | $394M | Sell |
|
|||||
|
2022
Q4 | $394M | Buy |
|
|||||
|
2022
Q3 | $330M | Buy |
|
|||||
|
2022
Q2 | $402M | Buy |
|
|||||
|
2022
Q1 | $396M | Buy |
|
|||||
|
2021
Q4 | $299M | Sell |
|
|||||
|
2021
Q3 | $214M | Buy |
|
|||||
|
2021
Q2 | $233M | Sell |
|
|||||
|
2021
Q1 | $209M | Buy |
|
|||||
|
2020
Q4 | $188M | Buy |
|
|||||
|
2020
Q3 | $135M | Buy |
|
|||||
|
2020
Q2 | $129M | Buy |
|
|||||
|
2020
Q1 | $68.2M | Buy |
|
|||||
|
2019
Q4 | $134M | Sell |
|
|||||
|
2019
Q3 | $29.7M | Buy |
|
|||||
|
2019
Q2 | $51.1M | Buy |
|
|||||
|
2019
Q1 | $46.9M | Sell |
|
|||||
|
2018
Q4 | $45.6M | Buy |
|
|||||
|
2018
Q3 | $85.2M | Buy |
|
|||||
|
2018
Q2 | $67.1M | Buy |
|
|||||
|
2018
Q1 | $79M | Sell |
|
|||||
|
2017
Q4 | $58M | Buy |
|
|||||
|
2017
Q3 | $52M | Sell |
|
|||||
|
2017
Q2 | $47.6M | Buy |
|
|||||
|
2017
Q1 | $58.1M | Buy |
|
|||||
|
2016
Q4 | $223K | Buy |
|
|||||
|
2016
Q3 | $216K | Sell |
|
|||||
|
2016
Q2 | $4.04M | Buy |
|
|||||
|
2016
Q1 | $2.85M | Buy |
|
|||||
|
2015
Q4 | $5.46M | Sell |
|
|||||
|
2015
Q3 | $4.65M | Buy |
|
|||||
|
2015
Q2 | $1.25M | Sell |
|
|||||
|
2015
Q1 | $2.32M | Hold |
|
|||||
|
2014
Q4 | $1.72M | Hold |
|
|||||
|
2014
Q3 | $1.33M | Sell |
|
|||||
|
2014
Q2 | $1.77M | Buy |
|
|||||
|
2014
Q1 | $1.91M | Buy |
|